Investors & Media


February 26, 2024

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP

February 20, 2024

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference

January 17, 2024

NGM Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

January 9, 2024

NGM Bio Announces New Clinical Data from Ongoing Trial of NGM707 in Advanced Solid Tumors and Outlines Evolved Strategy for Aldafermin and NGM120 to Focus on Rare Conditions with Significant Unmet Need

Contact Information

investor relations

media relations